Prevalence and Implications of Mogamulizumab-Induced Immune-Related Adverse Events in Patients With Mycosis Fungoides/Sézary Syndrome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prevalence and Implications of Mogamulizumab-induced Immune-related Adverse Events in Mycosis Fungoides/Sézary Syndrome, a single-center experience
J Am Acad Dermatol 2023 Jun 13;[EPub Ahead of Print], A Jfri, CA Virgen, M Tawa, A Giobbie-Hurder, TS Kupper, DC Fisher, NR LeBoeuf, C LaroccaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.